Cardiovascular-kidney-metabolic syndrome-related Age-Adjusted Mortality Rates per 1,000,000, Stratified by Census Regions in Adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

(A) Overall cardiovascular-kidney-metabolic syndrome-related Age-Adjusted Mortality Rates per 1,000,000 in Adults in the United States, 1999 to 2022, and (B) Sex-Stratified cardiov... by Aman Goyal (19231397)

Subjects:

Cardiovascular-kidney-metabolic syndrome-related Age-Adjusted Mortality Rates per 1,000,000, Stratified by State in Adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Cardiovascular-kidney-metabolic syndrome-related Age-Adjusted Mortality Rates per 1,000,000, Stratified by ethnoracial groups in Adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Comparison of Cardiovascular-kidney-metabolic syndrome-related-related Average Age-Adjusted Mortality Rates (AAMRs) per 1,000,000 during the COVID-19 Pandemic period (2020-2022) wi... by Aman Goyal (19231397)

Subjects:

Potato gene ontology enrichment results significant at <i>p</i> < 0.01. by Margaret A. Carpenter (6104180)

Genome-wide significant SNPs for meat L*15 min and a*15 min. by Jiahong Sun (6497603)

Statistically Significant Results for Heart Rate Variability (HRV) Indices for High and Low Authority Groups. by David Vagni (8060432)

Subjects:

Statistically Significant Results for Heart Rate Variability (HRV) Indices for High and Low Clarity Groups. by David Vagni (8060432)

Subjects:

Identification of ACADM, ANGPTL4, and NFKB2 as significant predictors of OS in the TCGA-KIRC cohort. by Yu Zhang (12946)

Subjects:

EF-24 induces significant transcriptional changes in K-562 cells. by Ajeet P. Singh (22298432)

Subjects:

Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

Subjects:

Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

Subjects:

Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

Subjects:

Lymphocyte proliferation assay following combination therapy with NDV. by Hedieh Zargaran (21410233)

Tumor volume measurements. by Hedieh Zargaran (21410233)